197905-69-4

Usage

Molecular structure

A complex and specific structure, containing a butanoic acid core, a phenyl group with a methylsulfanyl substituent, and an oxoethyl group.

Functional groups

Methyl ester, phenyl, methylsulfanyl, and oxoethyl groups.

Chemical properties

The compound is likely to exhibit various chemical properties due to its complex structure and functional groups. These properties may include reactivity, solubility, and stability, which would depend on the specific context in which the compound is used.

Biological properties

The compound may have a range of biological properties, such as potential pharmacological activity or interactions with biological systems. These properties would need to be investigated and confirmed through research and experimentation.

Research and pharmaceutical applications

Due to its unique structure and potential properties, 2-[2-(4-methylsulfanylphenyl)-2-oxoethyl]-3-oxobutanic acid methyl ester may be used in research and pharmaceutical applications to explore its potential uses and effects.

Context-dependent characteristics

The precise characteristics and uses of the compound would depend on its properties and behavior in specific contexts, such as its reactivity with other chemicals, solubility in various solvents, and stability under different conditions.

Upstream product

• 105-45-3 acetoacetic acid methyl ester 
• 42445-46-5 2-bromo-1-(4-methylsulfanyl-phenyl)-ethanone 

Downstream Products

• 1064453-40-2 (S)-2-ethoxy-3-(4-(2-(2-methyl-5-(4-(methylthio)phenyl)-1H-pyrrol-1-yl)ethoxy)phenyl)propanoic acid sodium salt 
• 494850-87-2 methanesulfonic acid 2-[2-methyl-5-(4-methylsulfanyl-phenyl)-pyrrol-1-yl]-ethyl ester 
• 494850-27-0 C₁₄H₁₇NOS 
• 189501-33-5 1-[4-(methylthio)phenyl]pentane-1,4-dione 

Relevant academic research and scientific papers

AN IMPROVED PROCESS FOR THE PREPARATION OF PYRROLE DERIVATIVES

The present invention relates to an improved process for the preparation of pyrroles derivatives having hypolipidemic and hypocholesteremic activities. In particular, the invention relates to an improved process for the preparation of 2- ethoxy-3-(4-(2-(2-methyl-5-(4-(methylthio)phenyl)-1H-pyrrol-1-yl)ethoxy) phenyl)propanoate and its pharmaceutically acceptable salts, hydrates, solvates, polymorphs or intermediates thereof. The invention also relates to an improved process for the preparation of mesylate compound (A1).

A PROCESS FOR PREPARATION OF PYRROLES HAVING HYPOLIPIDEMIC HYPOCHOLESTEREMIC ACTIVITIES

The present invention provides pyrroles having hypolipidemic hypocholesteremic activities. The invention provides saroglitazar and its pharmaceutically acceptable salts, hydrates, solvates, polymorphs or intermediates thereof. The invention also provides a process for the preparation of saroglitazar. The invention further provides intermediates as well process for preparation thereof.

1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses

Compounds of formula (I) and (II): STR1 ?wherein R is hydrogen, halogen or alkyl; R1 is alkyl, amino or substituted amino; R2 is optionally substituted phenyl; R3 is hydrogen, halogen or optionally substituted alkyl; R4 is hydrogen, optionally substituted alkyl, cycloalkyl, aryl, or aralkyl! have valuable analgesic, anti-inflammatory, anti-pyretic and anti-allergic activities and have the ability to inhibit the production of leukotrienes and to inhibit bone resorption. They are relatively free from the side effects which generally result from the administration of compounds having these kinds of activities.